🔎 Trials Near Me

መነሻ › Multiple Myeloma › Ohio › Columbus

በColumbus፣ OH ለMultiple Myeloma የሚደረጉ ክሊኒካዊ ጥናቶች

ለMultiple Myeloma የሚደረጉ 24 ጥናቶች በColumbus እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Study Site 104, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07582432

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • The James Cancer Hospital and Solove Research Institute At Ohio State University, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT04973605

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Ohio State University Medical Center Dept. of Internal Medicine, Division of Hematology, Columbus
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06052826

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Ohio State University, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07393282

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • The Ohio State University- James Cancer Hospital, Columbus
  • OhioHealth, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05552222

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Ohio State University Comprehensive Cancer Center, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06465316

Collection of Tissue Samples for Cancer Research

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Ohio State University, Columbus
2 Months · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT00900198

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06297226

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • Riverside Methodist Hospital, Columbus
  • Grant Medical Center, Columbus
  • እና 7 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT04566328

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Ohio State University, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT06292780

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦገስ 2026 · NCT07764978

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Ohio State University Comprehensive Cancer Center, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT07280013

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • The Ohio State University /ID# 271336, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ጁላይ 2026 · NCT06892522

Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Ohio State University Comprehensive Cancer Center, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁላይ 2026 · NCT07657312

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The Ohio State University James Cancer Hospital, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁላይ 2026 · NCT05137054

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Ohio State Medical Center, James Cancer Center, Columbus
  • Ohio Health Research Institute, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT05243797

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • The Ohio State University- The James Cancer Hospital and Solove Research Institute, Columbus
እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT06974786

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • The Ohio State University Comprehensive Cancer Center, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁን 2026 · NCT05145400

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

ተሳታዮችን በመፈለግ ላይ
  • Ohio State University Comprehensive Cancer Center, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ሜይ 2026 · NCT07609030

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The Ohio State University, Columbus
እድሜ 13 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT04771572

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ኤፕሪ 2026 · NCT06679101

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Ohio State University James Cancer Hospital, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኤፕሪ 2026 · NCT03761108

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ማርች 2026 · NCT04988555

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Ohio State University Medical Center, Columbus
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ማርች 2026 · NCT01408225

በሌሎች ከተሞች ለMultiple Myeloma የሚደረጉ ጥናቶች

በColumbus ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።